Agata Mularczyk

Agata Mularczyk

Auto-generated profile, based on publicly available information

Agata Mularczyk

Department of Obstetrics and Pathology of Pregnancy, Pomeranian Medical University

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 July 2020 in Journal of Education, Health and Sport
Verified
Journal Article
Closed access
PDF file
ASAnna Stangret
Anna Stangret
AMAgata Mularczyk
Agata Mularczyk
ASAngelika Szczęśniak
Angelika Szczęśniak
KTKatarzyna Topczewska
Katarzyna Topczewska
KRKarolina Rogulska
Karolina Rogulska
Temporomandibular joint (TMJ), due to its morphological structure, is a bicondylar joint, coupled in every movement. Intensive development of TMJ occurs in the early fetal period. Diseases of the temporomandibular joints differ in etiology and symptoms. The dysfunction of temporomandibular joint may lead to many problems connected with disorders of masseter muscles and bones building this joint and tissues around it. The aim of these studies is to describe several congenital abnormalities of the temporomandibular joint. Congenital deformities of the temporomandibular joint complex can present as a growth of mandible disturbances. They can occur as single condition characterized by hyperplasia or hypoplasia of joint structures. In extreme cases it can occure as agenesis, which is lack of formation. Tempotomandibular joint may be also affected by fibrous dysplasia, form of hyperplasia. They can also occur as a complex symptom with congenital mandible deformity, what can cause the problems with correct diagnosis. Temporomandibular joint disorders constitute a significant percentage of the viscerocranium diseases. All disorders occurring within these structures are usually associated with severe pain and significant discomfort. In dental practice, it is important to know in detail the symptoms associated with diseases of temporomandibular joint and also differentiate single conditions and complex symptoms.

13 September 2020 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
ASAngelika Szczęśniak
Angelika Szczęśniak
NSNatalia Serwin
Natalia Serwin
ECElżbieta Cecerska-Heryć
Elżbieta Cecerska-Heryć
ASAnna Stangret
Anna Stangret
AMAgata Mularczyk
Agata Mularczyk
KTKatarzyna Topczewska
Katarzyna Topczewska
During cancer therapy, patients undergo long-term treatment with chemotherapists. Unfortunately, although chemotherapy effectively destroys cancer cells, its toxicity may cause many adverse effects, weakening the patient's body. Their intensity is determined by many factors, including the age of the patient, the dose and type of drugs, the efficiency of metabolism and the occurrence of coexisting diseases. The most common side effects associated with chemotherapy include: myelosuppression, anaemia, neutropenia, thrombocytopenia, thrombocytopenia, thromboembolic disease, cardiovascular disorders, hair loss, nausea, diarrhoea, mucositis, taste change or fatigue.The complications that occur during or after chemotherapy are still a huge challenge for modern oncology. It is very important that the treatment of a patient with cancer is conducted by a team of doctors with many specializations. The individualization of treatment and the introduction of combined therapy may significantly minimize the occurrence of many serious complications, which may affect not only the quality of treatment, but also the patient life expectancy.

30 August 2020 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
MKMagdalena Kozioł
Magdalena Kozioł
NSNatalia Serwin
Natalia Serwin
MLMarcin Lewicki
Marcin Lewicki
IZIzabela Zawlik
Izabela Zawlik
AŁAnna Łopuszyńska
Anna Łopuszyńska
KGKonrad Grzeszczak
Konrad Grzeszczak
Introduction: The discovery of sodium-glucose co-transporter-2 inhibitors is attributed to phlorizin, which after oral administration caused the excretion of glucose in urine. Later studies showed that this effect was conditioned by SGLT-2 inhibition. However, this substance has not been used in the treatment of diabetes mellitus due to its non-selective action. Beeing also active against SGLT-1 transporters in alimentary tract, it causes osmotic diarrhea, dehydration and eventually malnutrition. Currently in Poland, gliflozins are used only in the treatment of diabetes mellitus, mainly type 2, especially with coexisting obesity and high cardio-vascular risk. However, as many human and animal studies show, the effect of SGLT2 inhibitors can be observed in many systems and organs.Results: The best known non-anti-diabetic action is the reduction of body fat and protection against fat accumulation following a high-calorie diet. These compounds reduce the production of endogenous fatty acids. Moreover, gliflozines lower the levels of cholesterol, triglycerides, uric acid and aminotransferases. They have a protective effect on the liver because they cause remission of nonalcoholic steatohepatitis (NASH), nonalcoholic fatty liver disease (NAFLD). They lower the cardiovascular risk and have an anti-inflammatory effect. Moreover, they inhibit vascular remodeling and improve hemodynamic conditions.Conclusions: According to many research, gliflozines have many collateral effects which can be used in the clinic as a treatment of diseases other than diabetes or coexisting with it. Obesity and cardiovascular diseases are among the most important health problems in the modern world. SGLT-2 inhibitors can prevent the above-mentioned diseases and reduce them.

1 October 2019 in Wiadomości Lekarskie
Verified
Journal Article
Closed access
MMMartyna Maciejewska
Martyna Maciejewska
IJInga Janik-Fuks
Inga Janik-Fuks
PZPatrycja Zielińska
Patrycja Zielińska
AMAgata Mularczyk
Agata Mularczyk
OSOlimpia Sipak
Olimpia Sipak
Artem Z. Aikian, Viktoriya I. Shynkevych, Igor P. Kaidashev QUANTITATIVE ASSESSMENT OF CD68+ AND CD163+ MACROPHAGES IN THE PRIMARY FOCUS AND METASTATIC LESIONS OF REGIONAL [Read more...]

1 September 2020 in Journal of Education, Health and Sport
Verified
Journal Article
Closed access
PDF file
PKPatrycja Kapczuk
Patrycja Kapczuk
KRKarolina Rogulska
Karolina Rogulska
ASAnna Stangret
Anna Stangret
AMAgata Mularczyk
Agata Mularczyk
ASAngelika Szczęśniak
Angelika Szczęśniak
KGKonrad Grzeszczak
Konrad Grzeszczak
The development of technology and a modern research approach in the 21st century has enabled access to new therapies in many fields of medicine and nanotechnology. Work on the use of cellular therapies is carried out in leading centers around the world. According to the "clinicaltraial.gov" service, it is estimated that there are about 5.5 thousand clinical trials using stem cells. The classification of stem cells is based on their potential to differentiate into other cells, tissues, organs or the whole organism. In cell therapy 3 groups of stem cells are used: Pluripotent Stem Cells (PSC), multipotent and unipotent, which have two common features: the ability to self-revalue, that is, to divide and to differentiate in many directions. To date, there are no objective, randomized clinical trials that would clearly determine the efficacy and safety of the cell therapy used in ophthalmic diseases. Hope is given by gene therapies such as the recently approved Luxturna™ gene therapy used in hereditary retinal degeneration caused by mutations in the RPE65 gene. Research is currently underway on experimental cell therapies to treat the following diseases of the optic system: glaucoma, retinopathy, age-related macular degeneration (AMD), optic nerve atrophy, retinal pigmentation (RP) and Stargardt's disease. Stem cell-based medical therapies are a promising and rapidly developing method of innovative treatment, especially for conditions that were previously considered incurable. The use of experimental cellular gene therapies in diseases of the visual organ gives hope to both patients and scientists, but the age of regenerative medicine has yet to come.

12 May 2020 in Pedagogy and Psychology of Sport
Verified
Journal Article
Closed access
PDF file
MHMagdalena Hagner-Derengowska
Magdalena Hagner-Derengowska
NSNatalia Serwin
Natalia Serwin
IZIzabela Zawlik
Izabela Zawlik
AKAnna Kałużna
Anna Kałużna
MCMichał Cichosz
Michał Cichosz
XŻXawery Żukow
Xawery Żukow
INTRODUCTION. A menstrual pain often contributes to the decline of a woman's life quality. It remains a serious problem in an everyday life, but also in a proffessional life of a sportwoman as it significantly affects the achieved results. Pharmacology is the most popular way to cease the menstrual pain. However, thanks to the development of physiotherapy, many methods of the menstrual pain management have been emerged and they are still evolving. It is in this regard especially noticebale that Kinesiology Taping should be paid rapt attention. AIM OF THE RESEARCH. The aim of the research is to assess Kinesiology Taping application in the reduction of menstrual pains among female basketball players. MATERIALS AND METHODOLOGY. The reaserch was conducted in a group of 35 women aged 20-36 with regular menstrual cycles and who train basketball professionaly. This group was for itself the study group and the control group. The assessment was conducted twice: 1) the first menstrual cycle after the research inclusion (no medical intervention); 2) the second menstrual cycle with the application of Kinesiology Taping. 3 day prior menstrual bleeding Kinesiology Taping was used among the participants of the reasearch. The 'I'-shaped cutting technique was used. The tapes tension was 50% and they were on women's bodies for 7 days. RESULTS. The average pain intensity in the NRS scale before the therapy was 5,525286 (median 6,00). Whereas after the therapy with the kinesiology taping application the decline of pain intensity was noted at the level of 3,428571 (median 3,00). The statistical analysis showed that the use of Kinesiology Taping had statistically significant – p